A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]

B. H. O'Neil; A. J. Scott; W. W. Ma; S. J. Cohen; L. Leichman; D. L. Aisner; A. R. Menter; M. A. Tejani; J. K. Cho; J. Granfortuna; L. Coveler; O. O. Olowokure; J. C. Baranda; M. Cusnir; P. Phillip; J. Boles; R. Nazemzadeh; M. Rarick; D. J. Cohen; J. Radford; L. Fehrenbacher; R. Bajaj; V. Bathini; P. Fanta; J. Berlin; A. J. McRee; R. Maguire; F. Wilhelm; M. Maniar; A. Jimeno; C. L. Gomes; W. A. Messersmith

doi:10.1093/annonc/mdv477

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]

B. H. O'Neil, A. J. Scott, W. W. Ma, S. J. Cohen, L. Leichman, D. L. Aisner, A. R. Menter, M. A. Tejani, J. K. Cho, J. Granfortuna, L. Coveler, O. O. Olowokure, J. C. Baranda, M. Cusnir, P. Phillip, J. Boles, R. Nazemzadeh, M. Rarick, D. J. Cohen, J. RadfordL. Fehrenbacher, R. Bajaj, V. Bathini, P. Fanta, J. Berlin, A. J. McRee, R. Maguire, F. Wilhelm, M. Maniar, A. Jimeno, C. L. Gomes, W. A. Messersmith

Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	2505
Number of pages	1
Journal	Annals of Oncology
Volume	26
Issue number	12
DOIs	https://doi.org/10.1093/annonc/mdv477
State	Published - Dec 1 2015

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdv477

Cite this

O'Neil, B. H., Scott, A. J., Ma, W. W., Cohen, S. J., Leichman, L., Aisner, D. L., Menter, A. R., Tejani, M. A., Cho, J. K., Granfortuna, J., Coveler, L., Olowokure, O. O., Baranda, J. C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D. J., ... Messersmith, W. A. (2015). A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]. Annals of Oncology, 26(12), 2505. https://doi.org/10.1093/annonc/mdv477

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]. / O'Neil, B. H.; Scott, A. J.; Ma, W. W. et al.

In: Annals of Oncology, Vol. 26, No. 12, 01.12.2015, p. 2505.

Research output: Contribution to journal › Comment/debate › peer-review

O'Neil, BH, Scott, AJ, Ma, WW, Cohen, SJ, Leichman, L, Aisner, DL, Menter, AR, Tejani, MA, Cho, JK, Granfortuna, J, Coveler, L, Olowokure, OO, Baranda, JC, Cusnir, M, Phillip, P, Boles, J, Nazemzadeh, R, Rarick, M, Cohen, DJ, Radford, J, Fehrenbacher, L, Bajaj, R, Bathini, V, Fanta, P, Berlin, J, McRee, AJ, Maguire, R, Wilhelm, F, Maniar, M, Jimeno, A, Gomes, CL & Messersmith, WA 2015, 'A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]', Annals of Oncology, vol. 26, no. 12, pp. 2505. https://doi.org/10.1093/annonc/mdv477

@article{6a25dee39e21437f85671758f9c5f939,

title = "A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]",

author = "O'Neil, {B. H.} and Scott, {A. J.} and Ma, {W. W.} and Cohen, {S. J.} and L. Leichman and Aisner, {D. L.} and Menter, {A. R.} and Tejani, {M. A.} and Cho, {J. K.} and J. Granfortuna and L. Coveler and Olowokure, {O. O.} and Baranda, {J. C.} and M. Cusnir and P. Phillip and J. Boles and R. Nazemzadeh and M. Rarick and Cohen, {D. J.} and J. Radford and L. Fehrenbacher and R. Bajaj and V. Bathini and P. Fanta and J. Berlin and McRee, {A. J.} and R. Maguire and F. Wilhelm and M. Maniar and A. Jimeno and Gomes, {C. L.} and Messersmith, {W. A.}",

year = "2015",

month = dec,

day = "1",

doi = "10.1093/annonc/mdv477",

language = "English (US)",

volume = "26",

pages = "2505",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]

AU - O'Neil, B. H.

AU - Scott, A. J.

AU - Ma, W. W.

AU - Cohen, S. J.

AU - Leichman, L.

AU - Aisner, D. L.

AU - Menter, A. R.

AU - Tejani, M. A.

AU - Cho, J. K.

AU - Granfortuna, J.

AU - Coveler, L.

AU - Olowokure, O. O.

AU - Baranda, J. C.

AU - Cusnir, M.

AU - Phillip, P.

AU - Boles, J.

AU - Nazemzadeh, R.

AU - Rarick, M.

AU - Cohen, D. J.

AU - Radford, J.

AU - Fehrenbacher, L.

AU - Bajaj, R.

AU - Bathini, V.

AU - Fanta, P.

AU - Berlin, J.

AU - McRee, A. J.

AU - Maguire, R.

AU - Wilhelm, F.

AU - Maniar, M.

AU - Jimeno, A.

AU - Gomes, C. L.

AU - Messersmith, W. A.

PY - 2015/12/1

Y1 - 2015/12/1

UR - http://www.scopus.com/inward/record.url?scp=84949942343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949942343&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdv477

DO - 10.1093/annonc/mdv477

M3 - Comment/debate

AN - SCOPUS:84949942343

SN - 0923-7534

VL - 26

SP - 2505

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this